Yu Ding
Chief Financial OfficerMr. Yu Ding serves as Chief Financial Officer at Indaptus Therapeutics, Inc. since April 1, 2026. He has extensive experience across commercial and financial markets. He has worked in capital management, strategic financial planning and cross-sectoral leadership. He served as VP, CFO & Executive Director at Grand Baoxin Auto Group Limited since August 25, 2023 until January 29, 2026. He served as the Chief Financial Officer at China New Higher Education Group Limited from April 23, 2018 to April 30, 2019 and its Executive Director from July 6, 2018 to April 30, 2019. From May 2019 to December 2019, he was the Vice President of China ZhengTong Auto Services Holdings Limited in Hong Kong. He was as the general manager of capital management of Grand Baoxin Auto Group Limited and China Grand Automotive Services Co., Ltd. From July 2005 to January 2011, he was head of finance department and senior management of Guo Sheng Pawn Co., Ltd, a subsidiary of Shanghai International Group, Meihao Holdings Group Co., Ltd. and Sinar Mas Paper (China) Investment Company Limited. Mr. Ding worked in two commercial banks, China Merchants Bank and Industrial Bank Co., Ltd., for ten years from July 1995 to June 2005. He graduated from the University of Canberra, Australia with a Master of Business Administration in November 2006 and from East China Normal University with a Bachelor's Degree in International Accounting in July 1995.
Positions
- Company NameIndaptus Therapeutics, Inc.Stock CodeINDPPositionChief Financial Officer
